At a time when life before COVID-19 seems like a dream, a vaccine rollout garnering the world’s attention offers a glimpse of hope for a return to pre-pandemic life. But, as with everything SARS-CoV-2-related, questions and uncertainties remain.
In response, CU Anschutz Today will tackle the issues as they arise throughout this next chapter of the pandemic. We will tap our top scholars and researchers and keep you apprised of the progress and setbacks during the historic campaign that lies ahead.
From the science behind the arsenal of vaccines created in response to the virus to the concerns about safety and racial barriers, we’ll leverage our educators to answer these questions related to a problem that affects everyone.
As one of our experts, Anuj Mehta, MD, put it: “We all want to travel. We all want to see loved ones. And I think we’re close. But we still need to be careful until the science catches up to tell us we can all go back to doing the things that we all really want to do.”
The series so far:
Eight Things You Should Know About Omicron
Delta Variant Takes Over COVID-19 Cases in Colorado: Should You Worry?